Follow The Filings

TT Trane Technologies

Industrials, filed as TRANE TECHNOLOGIES PLC (SHS), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Sold by 2 managers in 2026 Q2

  • 1 Owner
  • Max 0.1%
  • $339K
  • 1 reduce

In 2026 Q3 Murphy Pohlad trimmed Trane Technologies.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Murphy Pohlad, Murphy Pohlad Asset Management). Not free-float ownership.

  1. Murphy Pohlad Reduce 0.12%

Who owns TT

Sorted by value, long equity only, as of 2026 Q3.

History
Murphy Pohlad, Murphy Pohlad Asset Management 0.12%, was 0.17% Reduce −22.6% 750 $339K History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by TT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TT insider trades
  • $172K bought by 1 insider
  • $68K sold by 1 insider outside a trading plan
  • $75.8M sold by 4 insiders under 10b5-1 plans
  1. David S Regnery CEO
    Planned sale
    $23.1M 48,091 shares at $480.00 33% of stake
    Traded Oct 6 Filed Oct 8
    ↗
  2. David S Regnery CEO
    Planned sale
    $20.8M 43,778 shares at $475.00 31% of stake
    Traded Aug 5 Filed Aug 6
    ↗
  3. Melissa N. Schaeffer Director
    Sale
    $68K 145 shares at $472.27 6.9% of stake
    Traded Aug 4 Filed Aug 5
    ↗
  4. John A Hayes Director
    Buy
    $172K 400 shares at $430.44 New stake
    Traded Mar 5 Filed Jun 9
    ↗
  5. Donald E. Simmons Group President, Americas
    Planned sale
    $2.3M 4,593 shares at $500.00 55% of stake
    Traded Apr 30 Filed May 1
    ↗
  6. Christopher J Kuehn CFO
    Planned sale
    $3.9M 8,619 shares at $450.00 13% of stake
    Traded Apr 8 Filed Apr 9
    ↗
  7. Elizabeth A. Elwell VP & Chief Accounting Officer
    Planned sale
    $268K 635 shares at $422.71 8.2% of stake
    Traded Mar 6 Filed Mar 9
    ↗
  8. David S Regnery CEO
    Planned sale
    $15.2M 36,045 shares at $422.69 27% of stake
    Traded Mar 6 Filed Mar 9
    ↗
  9. Donald E. Simmons Group President, Americas
    Planned sale
    $1.6M 3,762 shares at $422.70 50% of stake
    Traded Mar 6 Filed Mar 9
    ↗
  10. Donald E. Simmons Group President, Americas
    Planned sale
    $3.6M 7,663 shares at $475.00 67% of stake
    Traded Feb 12 Filed Feb 17
    ↗
  11. Christopher J Kuehn CFO
    Planned sale
    $1.1M 2,389 shares at $462.70 3.8% of stake
    Traded Feb 10 Filed Feb 11
    ↗
  12. David S Regnery CEO
    Planned sale
    $2.6M 5,588 shares at $462.60 5.4% of stake
    Traded Feb 10 Filed Feb 11
    ↗
  13. Donald E. Simmons Group President, Americas
    Planned sale
    $380K 822 shares at $462.57 18% of stake
    Traded Feb 10 Filed Feb 11
    ↗
  14. Elizabeth A. Elwell VP & Chief Accounting Officer
    Planned sale
    $63K 137 shares at $462.48 1.9% of stake
    Traded Feb 10 Filed Feb 11
    ↗
  15. David S Regnery CEO
    Planned sale
    $445K 987 shares at $451.08 0.9% of stake
    Traded Feb 6 Filed Feb 10
    ↗

Also filed in the last 12 months, not counted as buying or selling: 31 share withholdings for taxes, 25 stock grants, and 5 option exercises.

Congress

5 members of Congress traded TT in the last three years: 3 buys and 11 sales. 9 members listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Sell $15K–$50K Mar 27 filed Jul 21
  2. Val T. Hoyle D-OR-4Spouse Sell $1K–$15K Sep 23, 2025 filed Oct 10, 2025
  3. Val T. Hoyle D-OR-4Spouse Buy $1K–$15K Oct 29, 2024 filed Sep 12, 2025
  4. Jefferson Shreve R-IN-6 Sell $50K–$100K May 12, 2025 filed Jun 22, 2025
  5. Jefferson Shreve R-IN-6 Buy $50K–$100K Apr 7, 2025 filed May 8, 2025
  6. Jefferson Shreve R-IN-6 Sell $15K–$50K Mar 5, 2025 filed Apr 11, 2025

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $17.68B $19.84B $21.32B
Net income $2.02B $2.57B $2.92B
Net margin * 11.4% 12.9% 13.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $6.87B $7.34B $7.86B
Total non-current assets * $12.52B $12.81B $13.56B
Total assets $19.39B $20.15B $21.42B
Total current liabilities $6.05B $6.07B $6.29B
Total non-current liabilities * $6.32B $6.59B $6.53B
Total equity $7B $7.46B $8.58B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $2.39B $3.15B $3.19B
Cash from investing -$1.17B -$0.563B -$0.64B
Cash from financing -$1.35B -$2.02B -$2.5B
Net change in cash -$125.2M $494.8M $173.2M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.